Omega Therapeutics

Provider of platform for human genome study for precision medicine

placeCambridge, Massachusetts, United States calendar_todayFounded 2016 groups93 employees language omegatherapeutics.com

Registered entities

Innovation

16 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 2,416 times.

YearFilings
20214
20226
20236
202410
20258
20261

Investor mix

11 investors on record; lead investors include Invus, Logos, Point72, Cowen.

Investor typeCountShare
Venture capital327%
Private equity218%
Bank & private debt327%
Other / undisclosed327%
Coming soon